2RY0 Stock Overview
A pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
China SXT Pharmaceuticals, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.35 |
| 52 Week High | US$3.42 |
| 52 Week Low | US$0.35 |
| Beta | 1.16 |
| 11 Month Change | -39.61% |
| 3 Month Change | -54.02% |
| 1 Year Change | -77.13% |
| 33 Year Change | -99.89% |
| 5 Year Change | -99.98% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2RY0 | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | -8.3% | -1.2% | -0.02% |
| 1Y | -77.1% | -20.1% | 8.2% |
Return vs Industry: 2RY0 underperformed the German Pharmaceuticals industry which returned -22% over the past year.
Return vs Market: 2RY0 underperformed the German Market which returned 7.4% over the past year.
Price Volatility
| 2RY0 volatility | |
|---|---|
| 2RY0 Average Weekly Movement | 16.4% |
| Pharmaceuticals Industry Average Movement | 6.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 2RY0's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 2RY0's weekly volatility has decreased from 26% to 16% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 75 | Albert Zhou | www.sxtchina.com |
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands.
China SXT Pharmaceuticals, Inc. Fundamentals Summary
| 2RY0 fundamental statistics | |
|---|---|
| Market cap | €1.30m |
| Earnings (TTM) | -€2.98m |
| Revenue (TTM) | €1.85m |
0.7x
P/S Ratio-0.4x
P/E RatioIs 2RY0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2RY0 income statement (TTM) | |
|---|---|
| Revenue | US$1.93m |
| Cost of Revenue | US$1.37m |
| Gross Profit | US$553.97k |
| Other Expenses | US$3.65m |
| Earnings | -US$3.10m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.89 |
| Gross Margin | 28.73% |
| Net Profit Margin | -160.67% |
| Debt/Equity Ratio | 24.8% |
How did 2RY0 perform over the long term?
See historical performance and comparison